feed,title,long_url,short_url
Benzinga,"Hypertrophic Cardiomyopathy Market to be Driven by the Emergence of Novel Pharmacotherapies & Gene-directed Approaches at a 22.24% CAGR During the Study Period [2018-2030], States DelveInsight",https://benzinga.com/pressreleases/21/08/n22472853/hypertrophic-cardiomyopathy-market-to-be-driven-by-the-emergence-of-novel-pharmacotherapies-gene-d,
